Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-010100

EVP, Head of R&D acquired 141,328 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dupont Jakob · EVP, Head of R&D

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-01 Grant or award : show line 1 in the form +141,328 295,868 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-01 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +317,987 317,987 D
Loading xslF345X03/form4.xml…